R&D Systems™ ProDots Recombinant Human GM-CSF

Catalog No.	Quantity
PRD21510	50 μg
PRD21550	250 μg

Catalog No. PRD21510 Supplier R&D Systems™ Supplier No. PRD21510

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The ProDots Recombinant Human GM-CSF Protein is derived from E. coli. The ProDots Recombinant Human GM-CSF Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: CAA26822
• For Use With (Application): Bioactivity
• Molecular Weight (g/mol): Predicted MW: 14kDa Observed MW: 14kDa, reducing conditions
• Name: ProDots™ Recombinant Human GM-CSF
• Quantity: 50 μg
• Source: E. coli-derived human GM-CSF protein Ala18-Glu144
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt at room temperature as supplied. 12 months from date of receipt at 2-8° C as supplied. 1 month at 2-8° C under sterile conditions after reconstitution. 3 months at -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: colony stimulating factor 2 (granulocyte-macrophage), Colony-stimulating factor, CSF, CSF2, CSF-2, GMCSF, GM-CSF, GMCSFgranulocyte-macrophage colony-stimulating factor, granulocyte-macrophage colony stimulating factor, MGC131935, MGC138897, Molgramostim, molgramostin, sargramostim
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: For a stock solution, reconstitute at 100 μg/mL in PBS containing = 0.1% human or bovine serum albumin, or simply roll ProDot™ directly into cell culture medium for immediate use.
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.